New World Development sold Artisan Lab in Kowloon, Hong Kong for HK$ 620 million. Sing Tao Daily quoted an unnamed insider as saying that New World Development sold Artisan Lab in San Po Kong, Kowloon for HK$ 620 million. This 22-storey building was completed in 2022, with a floor area of about 120,000 square feet.The detailed rules for the examination of egg products production license clearly require the transportation temperature of liquid eggs and frozen egg products, and the General Administration of Market Supervision publicly solicited opinions on the detailed rules for the examination of egg products production license (draft for comments). The deadline for feedback is January 11, 2025. The "Draft for Comment" clarifies that egg product manufacturers should formulate salmonella monitoring plans and implement effective monitoring in combination with production technology and product characteristics; Self-inspection enterprises should have inspection rooms and inspection capabilities suitable for the inspected items, and verify the inspection capabilities of the inspected items at least once a year. The use of rapid detection methods and equipment should be compared or verified with the inspection methods specified by national standards on a regular basis to ensure the accuracy of the test results. At the same time, the transportation temperature of liquid egg products should be controlled at 0-4℃, and the transportation temperature of frozen egg products should be controlled below -13℃.Trump appointed TOM BARRACK as the US ambassador to Turkey.
Expert: Central enterprises will continue to recruit in A-shares. On the evening of December 9, Huada Jiutian, a domestic EDA leader, announced that China Electronic Information Industry Group Co., Ltd. will become the actual controller of the company. So far, the number of A-share listed companies "incorporated" by central enterprises reached 10 in 2024. The end of 2024 is an important node for central enterprises to optimize the layout of listed platforms. The Work Plan for Improving the Quality of Listed Companies Controlled by Central Enterprises previously issued by the State-owned Assets Supervision and Administration Commission of the State Council made it clear that the adjustment and revitalization of the listing platform should be basically completed by the end of 2024, and it is supported to revitalize through absorption and merger, asset restructuring and cross-market operation, or to withdraw through free transfer and equity transfer, so as to further focus on the main business and advantageous areas. Looking forward to the next layout rhythm of central enterprises in the capital market, many experts interviewed by reporters believe that the pace of "recruiting" of central enterprises in A shares will continue. In the coming period, the cases of central enterprises strengthening their main business through capital operation and giving play to their strategic support and industrial leading functions will be on the rise. (shanghai securities news)Officials said that fighting broke out between the forces of Jubaland and the federal government in Somalia.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.
Goldman Sachs: I don't agree that gold can't reach $3,000 under a strong dollar. Goldman Sachs said that we don't agree with the view that the price of gold can't rise to $3,000 per ounce by the end of 2025 when the dollar remains strong for a long time. We predict that gold will reach $3,000 per ounce by the end of 2025, and the reduction of interest rate cuts by the Federal Reserve (rather than the strengthening of the US dollar) is the downside risk of this prediction.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Mercedes-Benz Group Co., Ltd. announced the personnel changes of the board of directors, and the Board of Supervisors of Mercedes-Benz Group Co., Ltd. decided the personnel changes of the board of directors. In 2025, Hubertus Troska, Sabine Kohleisen and Renata Jungo Brüngger, members of the board of directors of Mercedes-Benz Group, will retire after the contract expires. At the same time, the Board of Supervisors decided to appoint Oliver Thöne, Mathias Geisen and Olaf Schick as new board members.